What this instrument covers
The National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment (June Update) Instrument 2026 updates the rules that govern how the government funds chemotherapy drugs through the Efficient Funding of Chemotherapy special arrangement. The original arrangement was established in 2024 and is known as PB 31 of 2024.
Registration and operative period
The instrument was registered on 29 May 2026. It is in force from 29 May 2026 through to 7 September 2026.
What was changed
Changes are set out in Schedule 1 of the instrument. The source does not specify which particular chemotherapy items or funding rates were altered.
Enabling legislation
This instrument is administered under the National Health Act 1953 by the Department of Health and Ageing.
Where to find the instrument
The full text of the instrument, including Schedule 1, is available at the Federal Register of Legislation: https://www.legislation.gov.au/F2026L00649. Pharmacies or healthcare providers dispensing chemotherapy under this arrangement can review Schedule 1 at that address to check whether any listed items or funding conditions have changed before the instrument expires on 7 September 2026.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.